2021
DOI: 10.1002/jdn.10141
|View full text |Cite
|
Sign up to set email alerts
|

Transcription factors in neurodevelopmental and associated psychiatric disorders: A potential convergence for genetic and environmental risk factors

Abstract: Neurodevelopmental disorders (NDDs) are a heterogeneous and highly prevalent group of psychiatric conditions marked by impairments in the nervous system. Their onset occurs during gestation, and the alterations are observed throughout the postnatal life. Although many genetic and environmental risk factors have been described in this context, the interactions between them challenge the understanding of the pathways associated with NDDs. Transcription factors (TFs)—a group of over 1,600 proteins that can intera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 267 publications
(273 reference statements)
1
11
0
Order By: Relevance
“…Transcription and translation constitute key layers of dysfunction in NDDs (Ayhan and Konopka, 2019; Crino, 2016; Magdalon et al, 2017; Santos-Terra et al, 2021). Mutations in many TFs affect neurodevelopment by altering the activity of master regulators such as the RE-1 silencing transcription factor (REST), as shown for the high-confidence ASD/ID genes CHD8 and MECP2 (Ballas et al, 2005; Katayama et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Transcription and translation constitute key layers of dysfunction in NDDs (Ayhan and Konopka, 2019; Crino, 2016; Magdalon et al, 2017; Santos-Terra et al, 2021). Mutations in many TFs affect neurodevelopment by altering the activity of master regulators such as the RE-1 silencing transcription factor (REST), as shown for the high-confidence ASD/ID genes CHD8 and MECP2 (Ballas et al, 2005; Katayama et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…This study aims to unravel the role of MD GVs in genetic regulation by focusing on regulatory variation following two complementary approaches: cis-eQTLs and TF binding alterations. Both are key to identifying potentially causal genes and understanding gene expression regulation [6, 8]; as reported by supporting evidence for its association with other mental disorders [40][41][42] and with MD in particular [43][44][45]. The regulatory variation analysis pipelines we have designed and implemented involve ne-mapping, cis-eQTL colocalization, transcription factor binding analysis and chromatin accessibility data; specially designed to perform well when full-genome summary statistics are not available [46].…”
Section: Discussionmentioning
confidence: 99%
“…This study aims to unravel the role of MD GVs in genetic regulation by focusing on regulatory variation following two complementary approaches: cis-eQTLs and TF binding alterations. Both are key to identifying potentially causal genes and understanding gene expression regulation [ 6 , 8 ], as reported by supporting evidence for its association with other mental disorders [ 53 , 54 , 55 ] and with MD in particular [ 56 , 57 , 58 ]. The regulatory variation analysis pipelines we have implemented involve fine-mapping, cis-eQTL colocalization, transcription factor binding analysis, and chromatin accessibility data, specially designed to perform well when full-genome summary statistics are not available [ 59 ].…”
Section: Discussionmentioning
confidence: 99%